Other substances

Cisplatin

Phase of research

Potential treatment - pre-clinical evidence

How it helps

Antiviral

Drug status

Used to treat other disease

Supporting references

Contradictory references

AI-suggested references

Clinical trials

Supporting references

Link	Tested on	Impact factor	Notes	Publication date
Targeting ACE2-RBD interaction as a platform for COVID19 therapeutics: Development and drug repurposing screen of an AlphaLISA proximity assay Preprint Screening	in vitro		inhibitor of the ACE2-RBD interaction	Jun/16/2020

AI-suggested references

Link	Publication date
Encouraging Pathological Complete Response Rate from Neoadjuvant Chemotherapy with Albumin-Bound Paclitaxel Plus Cisplatin and Capecitabine for Locally Advanced Esophageal Squamous Carcinoma: Preliminary Outcome of a Retrospective Study	Mar/02/2021
Combination treatments with hydroxychloroquine and azithromycin are compatible with the therapeutic induction of anticancer immune responses	Jul/08/2020
Synthesis of Palladium(II) Complexes via Michael Addition: Antiproliferative Effects through ROS-Mediated Mitochondrial Apoptosis and Docking with SARS-CoV-2	Nov/24/2020
Synthesis, cytotoxicity and docking studies (with SARS-CoV-2) of water-soluble binuclear Ru-p-cymene complex holding indole thiosemicarbazone ligand	Oct/28/2021
Complete remission of stage IV sinonasal small cell neuroendocrine carcinoma: A case report.	Dec/23/2021
Cemiplimab for Cisplatin Resistant Metastatic Penile Cancer	Jun/21/2021
In vitro and in vivo identification of clinically approved drugs that modify ACE2 expression	Feb/11/2021
Four Cycles of Etoposide plus Cisplatin for Patients with Good-Risk Advanced Germ Cell Tumors	Mar/12/2021
Natural Products, Alone or in Combination with FDA-Approved Drugs, to Treat COVID-19 and Lung Cancer.	Jun/18/2021
Targeting CX3CR1 Suppresses the Fanconi Anemia DNA Repair Pathway and Synergizes with Platinum.	Mar/22/2021
Drug repurposing for coronavirus (SARS-CoV-2) based on gene co-expression network analysis	Jul/12/2021
Design and synthesis of heterocyclic azole based bioactive compounds: Molecular structures, quantum simulation, and mechanistic studies through docking as multi-target inhibitors of SARS-CoV-2 and cytotoxicity	Nov/18/2020